dc.date.accessioned2020-04-20T19:47:26Z
dc.date.accessioned2022-10-18T23:09:05Z
dc.date.available2020-04-20T19:47:26Z
dc.date.available2022-10-18T23:09:05Z
dc.date.created2020-04-20T19:47:26Z
dc.date.issued2017
dc.identifierhttp://hdl.handle.net/10533/241705
dc.identifier3140455
dc.identifierWOS:000413705700028
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4473039
dc.description.abstractThe human Respiratory Syncytial Virus (hRSV) causes lower respiratory tract infections including pneumonia and bronchiolitis. Such infections also cause a large number of hospitalizations and affects mainly newborns, young children and the elderly worldwi
dc.languageeng
dc.relationhttps://doi.org/10.1080/21645515.2017.1334026
dc.relation10.1080/21645515.2017.1334026
dc.titleA safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
dc.typeArticulo


Este ítem pertenece a la siguiente institución